(Q49250557)

19 February 2018

title

PCNA-immunoreactivity in the uterus of rats after treatment with the antiestrogen tamoxifen. (English)

1 reference

19 February 2018

1 reference

Rumpel E

1

1 reference

19 February 2018

Michna H

series ordinal

2

1 reference

19 February 2018

Kühnel W

series ordinal

3

1 reference

19 February 2018

publication date

1 March 1995

1 reference

19 February 2018

published in

Annals of Anatomy

1 reference

19 February 2018

volume

177

1 reference

19 February 2018

issue

2

1 reference

19 February 2018

page(s)

133-138

1 reference

19 February 2018

MITOTIC RATES, RENEWAL TIMES, AND CYTODYNAMICS OF THE FEMALE GENITAL TRACT EPITHELIA IN THE RAT

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Tamoxifen decreases the estradiol induced progesterone receptors by interfering with nuclear estrogen receptor accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

The effects of oestrogen and progesterone on uterine cell division and epithelial morphology in spayed, adrenalectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Binding of estrogen and antiestrogen in uterine cell nuclei: in vivo autoradiographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

The pharmacology and clinical uses of tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted Triphenylethylenes

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Comparison of effects of estertrol and tamoxifen with those of estriol and estradiol on the immature rat uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

The role of tamoxifen in the treatment and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Geometric isomers of substituted triphenylethylenes and antiestrogen action

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Anti-oestrogenic and anti-tumour properties of prolonged tamoxifen therapy in C3H/OUJ mice

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Modulation of uterine morphology and growth by estradiol-17beta and an estrogen antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Estrogen agonistic and antagonistic action of 8 non-steroidal antiestrogens on progestin receptor induction in rat pituitary gland and uterus.

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

The number of proliferating cell nuclear antigen positive cells in endometriotic lesions differs from that in the endometrium. Analysis of PCNA positive cells during the menstrual cycle and in post-menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Estrogen use and cancer risk: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Stimulatory and Inhibitory Effects of Estrogen and Antiestrogen on Uterine Cell Division*

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Modification by progesterone of oestradiol-induced cell proliferation, RNA synthesis and oestradiol distribution in the rat uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0940-9602%2811%2980060-9

7 January 2021

10.1016/S0940-9602(11)80060-9

Identifiers

DOI

0 references

PubMed ID

7741272

1 reference

19 February 2018